•
Danish Endometrial Cancer Study
–
1166 patients, surgery alone
–
Vaginal recurrence: low risk 6.3%, intermediate risk 22%
–
Curative treatment: 100% CR, 74% cured
•
Must give sufficient dose (>65 Gy)
–
EBRT boost
–
Interstitial boost
–
IMRT
Ørtoft G, et al. Int J Gynecol Cancer. 2013; 23(8):1429-37
Vault recurrence